US VENTURE PARTNERS X LP 13D and 13G filings for eFFECTOR Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-08-18 8:04 pm Purchase |
2022-05-10 | 13D | eFFECTOR Therapeutics, Inc. EFTR |
US VENTURE PARTNERS X LP | 179,223 10.800% |
179,223 (New Position) |
Filing |
| 2022-08-18 7:54 pm Sale |
2022-08-09 | 13D | eFFECTOR Therapeutics, Inc. EFTR |
US VENTURE PARTNERS X LP | 0 0.000% |
-192,885 (Position Closed) |
Filing |
| 2021-09-13 06:23 am Purchase |
2021-08-25 | 13D | eFFECTOR Therapeutics, Inc. EFTR |
US VENTURE PARTNERS X LP | 192,885 11.900% |
192,885 (New Position) |
Filing |